OraSure Technologies Inc. - Form 8-K Summary
Business Context and Reporting Period
Company: OraSure Technologies, Inc.
Filing Date: July 10, 2012
Reporting Period: Event date of July 10, 2012
Context: The Company entered into a Material Definitive Agreement regarding an underwritten public offering of common stock.
Key Financial Metrics
This filing reports on a capital raising event rather than operational financial performance. Specific metrics regarding revenue, profit, cash flow, margins, or existing debt are not provided in this document.
| Metric | Value |
|---|---|
| Shares Offered | 6,100,000 |
| Offering Price | $12.30 per share |
| Over-Allotment Option | Up to 915,000 additional shares |
| Expected Net Proceeds (Base) | Approximately $70.2 million |
| Expected Net Proceeds (With Option) | Approximately $80.8 million |
Material Changes
The primary material change is the execution of an Underwriting Agreement with Citigroup Global Markets Inc. and Jefferies & Company, Inc. as representatives. This agreement facilitates the issuance of new equity, which will increase the Company's cash position upon closing, subject to customary conditions.
Guidance, Outlook, and Risks
- Outlook: The Company expects to receive net proceeds of approximately $70.2 million, or $80.8 million if the underwriters exercise their 30-day option to purchase additional shares.
- Closing Date: Shares are expected to be delivered on or about July 16, 2012.
- Risks/Contingencies: The transaction is subject to the satisfaction of customary closing conditions. The filing notes that the Underwriting Agreement contains customary representations, warranties, covenants, and indemnification rights.
- Management Commentary: The filing references a press release (Exhibit 99.1) announcing the pricing but does not contain detailed management commentary within the text of the 8-K itself.
Investor Verification Checklist
- Verify the final closing date and whether the underwriters exercised the 915,000 share over-allotment option.
- Review the final prospectus supplement to confirm the exact net proceeds after all offering expenses.
- Check subsequent filings (e.g., 10-Q or 10-K) to determine how the raised capital was utilized.
- Confirm the total number of outstanding shares post-offering to assess dilution impact.